PMCB stock

PharmaCyte Biotech Inc (PMCB) earnings · $8.6M cap

These earnings events as JSON? API free 100/day

PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.

This PMCB earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.

Latest reported PMCB revenue for 2026-04-30 was $0. Net income was -$19.4M. PMCB currently screens at market cap $8.6M.

When the next PMCB 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.

Period-over-period revenue change is not in cache for PMCB. We will not invent a beat or miss.

Not investment advice. Full PMCB research stays on the stock page; the tape stays on the quote page.

PMCB earnings FAQ

What is PMCB's latest net income?

Latest cached PharmaCyte Biotech Inc (PMCB) net income was -$19.4M. Statements: https://lician.com/financials/pmcb

What is PMCB's latest diluted EPS?

Latest cached PharmaCyte Biotech Inc (PMCB) diluted EPS for Apr 30, 2026 was -$2.77.

What period does the latest PMCB earnings print cover?

The latest cached PharmaCyte Biotech Inc (PMCB) earnings print covers Apr 30, 2026. The prior cached period on this page is Apr 30, 2025.

Where are PMCB earnings listed?

Cached earnings facts for PharmaCyte Biotech Inc (PMCB) are listed at https://lician.com/earnings/pmcb. Statements: https://lician.com/financials/pmcb

Not investment advice.

Full PMCB analysis